AGONISTS OF NEUROTROPHIN RECEPTORS AND THEIR USE AS MEDICAMENTS Russian patent published in 2017 - IPC C07K5/08 A61K38/06 A61P25/00 C07D207/04 C07D207/27 

Abstract RU 2606622 C2

FIELD: pharmaceutics.

SUBSTANCE: invention relates to compounds of Formula (II), or pharmaceutically acceptable salts thereof, which have receptor agonists activity of neurotrophin. Formula (II) R1 is phenyl substituted with halogen or trifluoromethyl and further optionally substituted with one or two substituents selected from the group, consisting of halogen, C1-6 alkyl, (C1-6)alkoxy and halo(C1-6)alkyl; R2 is 2-oxo-pyrrolidin-1-ylmethyl or sulfamoylphenyl.

EFFECT: invention relates to the pharmaceutical composition, method for production thereof, use of said compounds as an active ingredient for the manufacture of a drug for preventing or treating various diseases, as well as for preventing or treating nerve cell death or damage, methods for preventing or treating nerve cell death or damage, neuroprotection, regeneration of nerve cells, stimulation of the activity of brain-derived neurotrophic factor, methods for preventing or treating various diseases, including responsive to the stimulation of the activity of nerve growth factor, or a nerve growth factor receptor, neurotrophic factor or receptor of neurotrophic factor.

57 cl, 14 dwg, 17 ex

Similar patents RU2606622C2

Title Year Author Number
ANTI-NERVE GROWTH FACTOR (NGF) ANTIBODIES POSSESSING HIGH STABILITY IN VIVO 2010
  • Pauehll, Dzhon
  • Maginn, Mark
  • Kasson, Dunkan
  • Best, Andrea
  • Dutta, Sandip
  • Kholl, Dzherri, A.
  • Lju, Vehj
RU2549679C2
COMPOSITION OF COMPOUNDS AND WAYS OF THEIR APPLICATION 2015
  • Wu, Jay Jie-Qiang
RU2659068C1
METHOD OF PRODUCING MAMMAL EMBRYONIC STEM CELLS MODIFIED WITH HUMAN NERVE GROWTH FACTOR GENE 2011
  • Antonov Stanislav Anatol'Evich
  • Arsen'Eva Elena L'Vovna
  • Grivennikov Igor' Anatol'Evich
  • Kostrov Sergej Viktorovich
  • Manuilova Ekaterina Semenovna
  • Novosadova Ekaterina Vjacheslavovna
  • Safina Dina Rashidovna
  • Khajdarova Nella Vasil'Evna
RU2458984C1
NEUROGENESIS MEDIATED WITH 4-ACYLAMINOPYRIDINE DERIVATIVES 2007
  • Barlou Karroli
RU2451512C2
N-(2-THIAZOLYL)AMIDE DERIVATIVES AS GSK-3 INHIBITORS 2007
  • Martines Khil Ana
  • Kastro Morera Ana
  • Medina Padil'Ja Migel'
  • Martin Aparisio Ehster
  • Alonso Kaskon Mersedes
  • Fuehrtes Uehrta Ana
  • Navarro Riko Marija Luiza
  • Peres Puehrto Marija Khose
  • Del' Monte Mil'Jan Marija
RU2450000C2
COMPOUNDS AND METHODS 2015
  • Li, Peng
  • Zheng, Hailin
  • Zhao, Jun
  • Wennogle, Lawrence
RU2711442C2
1-((3S,4R)-4-(3-FLUOROPHENYL)-1-(2-METHOXYETHYL)PYRROLIDIN-3-YL)-3-(4-METHYL-3-(2-METHYLPYRIMIDIN-5-YL)-1-PHENYL-1N-PYRAZOL-5-YL)UREA AS A TRKA KINASE INHIBITOR 2015
  • Allen Shelli
  • Endryus Stiven U.
  • Baer Brajan
  • Krejn Zekeri
  • Lyu Vejdun
  • Uotson Deniel Dzhon
RU2719489C2
DIKETONES AND HYDROXYKETONES AS ACTIVATORS OF CATENIN SIGNALLING PATHWAY 2011
  • Ks Sunil Kumar
  • Uollejs Devid Mark
  • Khud Dzhon
  • Barroga Sharlin F.
RU2592694C2
7-[2-[4-(6-FLUORO-3-METHYL-1,2-BENZIOXAZOL-5-YL)-1-PIPERAZINYL]ETHYL]-2-(PROPYNYL)-7H-PYRAZOLO-[4, 3-e]-[1, 2, 4]-TRIAZOLO-[1, 5-c]PYRIMIDINE-5-AMINE 2006
  • Bojl Krejg D.
  • Chakkalamannil Samjuehl'
  • Shakh Unmesh G.
  • Lakhovich Zhan Eh.
RU2417997C2
N-(2-THIAZOLYL)AMIDE DERIVATIVES AS GSK-3 INHIBITORS 2007
  • Martines Khil Ana
  • Kastro Morera Ana
  • Medina Padil'Ja Migel'
  • Martin Aparisio Ehster
  • Alonso Kaskon Mersedes
  • Fuehrtes Uehrta Ana
  • Navarro Riko Marija Luiza
  • Peres Puehrto Marija Khose
  • Del' Monte Mil'Jan Marija
RU2429237C2

RU 2 606 622 C2

Authors

Villoslada Pablo

Messeguer Ankhel

Dates

2017-01-10Published

2011-08-31Filed